Literature DB >> 17005636

Efficient reactivation of latent herpes simplex virus from mouse central nervous system tissues.

Shih-Heng Chen1, Hui-Wen Yao, Wen-Yen Huang, Kuei-Sen Hsu, Huan-Yao Lei, Ai-Li Shiau, Shun-Hua Chen.   

Abstract

For decades, numerous ex vivo studies have documented that latent herpes simplex virus (HSV) reactivates efficiently from ganglia, but rarely from the central nervous systems (CNS), of mice when assayed by mincing tissues before explant culture, despite the presence of viral genomes in both sites. Here we show that 88% of mouse brain stems reactivated latent virus when they were dissociated into cell suspensions before ex vivo explant culture. The efficient reactivation of HSV from the mouse CNS was demonstrated with more than one viral strain, viral serotype, and mouse strain, further indicating that the CNS can be an authentic latency site for HSV with the potential to cause recurrent disease.

Entities:  

Mesh:

Year:  2006        PMID: 17005636      PMCID: PMC1676271          DOI: 10.1128/JVI.01232-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Failure of thymidine kinase-negative herpes simplex virus to reactivate from latency following efficient establishment.

Authors:  Shih-Heng Chen; Angela Pearson; Donald M Coen; Shun-Hua Chen
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Latent infection of the peripheral ANS with herpes simplex virus.

Authors:  R W Price; B J Katz; A L Notkins
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

3.  Anterior insular cortex: linking intestinal pathology and brain function in autism-spectrum subgroups.

Authors:  T Binstock
Journal:  Med Hypotheses       Date:  2001-12       Impact factor: 1.538

4.  The herpes simplex virus type 1 locus that encodes the latency-associated transcript enhances the frequency of encephalitis in male BALB/c mice.

Authors:  Clinton Jones; Melissa Inman; Weiping Peng; Gail Henderson; Alan Doster; Guey-Chuen Perng; Anisa Kaenjak Angeletti
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation.

Authors:  F B Knotts; M L Cook; J G Stevens
Journal:  J Infect Dis       Date:  1974-07       Impact factor: 5.226

6.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

7.  Herpes simplex virus in latent infection.

Authors:  H Marsden
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

8.  Detection of herpes-simplex viral genome in brain tissue.

Authors:  L W Sequiera; L C Jennings; L H Carrasco; M A Lord; A Curry; R N Sutton
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

9.  Herpesviruses in brains in Alzheimer's and Parkinson's diseases.

Authors:  Niina Hemling; Matias Röyttä; Juha Rinne; Paju Pöllänen; Eeva Broberg; Virpi Tapio; Tero Vahlberg; Veijo Hukkanen
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

10.  Latent herpes simplex virus in the central nervous system of rabbits and mice.

Authors:  F B Knotts; M L Cook; J G Stevens
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  17 in total

1.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

2.  Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.

Authors:  Chandra M Menendez; Jeremy K Jinkins; Daniel J J Carr
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

3.  Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.

Authors:  Chih-Yu Huang; Hui-Wen Yao; Li-Chiu Wang; Fang-Hsiu Shen; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 4.  Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection.

Authors:  Chandra M Menendez; Daniel J J Carr
Journal:  J Neuroimmunol       Date:  2017-03-08       Impact factor: 3.478

5.  Herpes Simplex Virus Type 1 Preferentially Enhances Neuro-Inflammation and Senescence in Brainstem of Female Mice.

Authors:  Mahesh Kumar Sivasubramanian; Raisa Monteiro; Kelly S Harrison; Bhuvana Plakkot; Madhan Subramanian; Clinton Jones
Journal:  J Virol       Date:  2022-08-17       Impact factor: 6.549

6.  Suppression of transcription factor early growth response 1 reduces herpes simplex virus lethality in mice.

Authors:  Shih-Heng Chen; Hui-Wen Yao; I-Te Chen; Biehuoy Shieh; Ching Li; Shun-Hua Chen
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

7.  In vivo reactivation of latent herpes simplex virus 1 in mice can occur in the brain before occurring in the trigeminal ganglion.

Authors:  Hui-Wen Yao; Pin Ling; Yuk-Ying Tung; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

8.  The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis.

Authors:  Patric Lundberg; Chandran Ramakrishna; Jeffrey Brown; J Michael Tyszka; Mark Hamamura; David R Hinton; Susan Kovats; Orhan Nalcioglu; Kenneth Weinberg; Harry Openshaw; Edouard M Cantin
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

9.  The furin-S2' site in avian coronavirus plays a key role in central nervous system damage progression.

Authors:  Jinlong Cheng; Ye Zhao; Yanxin Hu; Jing Zhao; Jia Xue; Guozhong Zhang
Journal:  J Virol       Date:  2021-03-16       Impact factor: 5.103

Review 10.  Directional spread of alphaherpesviruses in the nervous system.

Authors:  Tal Kramer; Lynn W Enquist
Journal:  Viruses       Date:  2013-02-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.